Titre : Thromboembolisme veineux

Thromboembolisme veineux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Lymph Node Excision
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Thromboembolisme veineux : Questions médicales les plus fréquentes", "headline": "Thromboembolisme veineux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Thromboembolisme veineux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-21", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Thromboembolisme veineux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Thromboembolie", "url": "https://questionsmedicales.fr/mesh/D013923", "about": { "@type": "MedicalCondition", "name": "Thromboembolie", "code": { "@type": "MedicalCode", "code": "D013923", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.355.590" } } }, "about": { "@type": "MedicalCondition", "name": "Thromboembolisme veineux", "alternateName": "Venous Thromboembolism", "code": { "@type": "MedicalCode", "code": "D054556", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Jean M Connors", "url": "https://questionsmedicales.fr/author/Jean%20M%20Connors", "affiliation": { "@type": "Organization", "name": "Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA." } }, { "@type": "Person", "name": "Francis Couturaud", "url": "https://questionsmedicales.fr/author/Francis%20Couturaud", "affiliation": { "@type": "Organization", "name": "CHU Brest, Département de Médecine Interne et Pneumologie, Brest, France; Univ_Brest, INSERM U1304-GETBO, CIC INSERM 1412, F29609 Brest; FCRIN INNOVTE network, Saint-Etienne, France. Electronic address: francis.couturaud@chu-brest.fr." } }, { "@type": "Person", "name": "Susan R Kahn", "url": "https://questionsmedicales.fr/author/Susan%20R%20Kahn", "affiliation": { "@type": "Organization", "name": "Department of Medicine, McGill University, Montreal, QC, Canada; Division of Internal Medicine and Division of Clinical Epidemiology, Jewish General Hospital/Lady Davis Institute, Montreal, QC, Canada." } }, { "@type": "Person", "name": "Marc Blondon", "url": "https://questionsmedicales.fr/author/Marc%20Blondon", "affiliation": { "@type": "Organization", "name": "Service d'angiologie et d'hémostase, HUG, 1211 Genève 14, et Faculté de médecine, Université de Genève, 1211 Genève 4." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Predictive Value of Jugulo-omohyoid Lymph Nodes in Lateral Lymph Node Metastasis of Papillary Thyroid Cancer.", "datePublished": "2024-05-21", "url": "https://questionsmedicales.fr/article/38773428", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12902-024-01576-7" } }, { "@type": "ScholarlyArticle", "name": "Radiation, Lymph Node Dissection, or Both: Management of Lymph Node Micrometastases from Merkel Cell Carcinoma.", "datePublished": "2023-04-27", "url": "https://questionsmedicales.fr/article/37106277", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1245/s10434-023-13437-z" } }, { "@type": "ScholarlyArticle", "name": "Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasized low rectal cancer.", "datePublished": "2022-12-28", "url": "https://questionsmedicales.fr/article/36577899", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00423-022-02739-7" } }, { "@type": "ScholarlyArticle", "name": "Robotic versus laparoscopic total mesorectal excision with lateral lymph node dissection for advanced rectal cancer: A systematic review and meta-analysis.", "datePublished": "2024-05-29", "url": "https://questionsmedicales.fr/article/38809911", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0304031" } }, { "@type": "ScholarlyArticle", "name": "Inguinal Lymph-Node Ratio (LNR) as a predictor of Pelvic Lymph-Node Metastasis in squamous cell carcinoma of penis.", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37315351", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.suronc.2023.101964" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Embolie et thrombose", "item": "https://questionsmedicales.fr/mesh/D016769" }, { "@type": "ListItem", "position": 5, "name": "Thromboembolie", "item": "https://questionsmedicales.fr/mesh/D013923" }, { "@type": "ListItem", "position": 6, "name": "Thromboembolisme veineux", "item": "https://questionsmedicales.fr/mesh/D054556" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Thromboembolisme veineux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Thromboembolisme veineux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Thromboembolisme veineux", "description": "Comment diagnostiquer un thromboembolisme veineux ?\nQuels tests sont utilisés pour confirmer un TEV ?\nQuels signes cliniques indiquent un TEV ?\nLe scanner est-il utile pour le TEV ?\nComment évaluer le risque de TEV ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Thromboembolisme veineux", "description": "Quels sont les symptômes d'un TEV ?\nComment se manifeste une embolie pulmonaire ?\nLe TEV peut-il être asymptomatique ?\nQuels signes alertent sur un TEV ?\nLes symptômes varient-ils selon l'emplacement ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Thromboembolisme veineux", "description": "Comment prévenir le TEV ?\nLes bas de compression aident-ils ?\nQuand est-il crucial de prévenir le TEV ?\nLes voyages longs augmentent-ils le risque ?\nL'activité physique réduit-elle le risque ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Thromboembolisme veineux", "description": "Quels traitements sont disponibles pour le TEV ?\nComment fonctionnent les anticoagulants ?\nQuand utiliser la thrombolyse ?\nQuels sont les effets secondaires des anticoagulants ?\nLe traitement préventif est-il nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Thromboembolisme veineux", "description": "Quelles sont les complications du TEV ?\nL'embolie pulmonaire est-elle grave ?\nQu'est-ce que le syndrome post-thrombotique ?\nLe TEV peut-il entraîner des problèmes cardiaques ?\nComment gérer les complications du TEV ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Thromboembolisme veineux", "description": "Quels sont les principaux facteurs de risque du TEV ?\nL'âge influence-t-il le risque de TEV ?\nLes femmes enceintes sont-elles à risque ?\nLes antécédents de TEV augmentent-ils le risque ?\nLe tabagisme est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un thromboembolisme veineux ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique, l'échographie Doppler et les tests sanguins." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer un TEV ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'échographie, le D-dimère et parfois l'angiographie." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un TEV ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent douleur, œdème, rougeur et chaleur dans la zone affectée." } }, { "@type": "Question", "name": "Le scanner est-il utile pour le TEV ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le scanner thoracique peut détecter une embolie pulmonaire associée." } }, { "@type": "Question", "name": "Comment évaluer le risque de TEV ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des scores comme le score de Wells aident à évaluer le risque de TEV." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un TEV ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, gonflement, chaleur et rougeur dans la jambe." } }, { "@type": "Question", "name": "Comment se manifeste une embolie pulmonaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une douleur thoracique, essoufflement et parfois toux avec sang." } }, { "@type": "Question", "name": "Le TEV peut-il être asymptomatique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains cas de TEV peuvent ne présenter aucun symptôme visible." } }, { "@type": "Question", "name": "Quels signes alertent sur un TEV ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Un gonflement soudain d'une jambe et une douleur intense sont des signes d'alerte." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'emplacement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon que le caillot est dans une veine profonde ou pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir le TEV ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut l'exercice régulier, l'hydratation et l'utilisation d'anticoagulants si nécessaire." } }, { "@type": "Question", "name": "Les bas de compression aident-ils ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bas de compression aident à améliorer la circulation sanguine et à prévenir le TEV." } }, { "@type": "Question", "name": "Quand est-il crucial de prévenir le TEV ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Après une chirurgie ou lors d'une immobilisation prolongée, la prévention est cruciale." } }, { "@type": "Question", "name": "Les voyages longs augmentent-ils le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages prolongés en position assise augmentent le risque de TEV." } }, { "@type": "Question", "name": "L'activité physique réduit-elle le risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'activité physique régulière aide à réduire le risque de formation de caillots." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le TEV ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les anticoagulants, la thrombolyse et parfois la chirurgie." } }, { "@type": "Question", "name": "Comment fonctionnent les anticoagulants ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils empêchent la formation de nouveaux caillots et aident à dissoudre les existants." } }, { "@type": "Question", "name": "Quand utiliser la thrombolyse ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thrombolyse est utilisée dans les cas graves d'embolie pulmonaire pour dissoudre rapidement le caillot." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des anticoagulants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent des saignements, des ecchymoses et des réactions allergiques." } }, { "@type": "Question", "name": "Le traitement préventif est-il nécessaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chez les patients à risque, un traitement préventif est souvent recommandé." } }, { "@type": "Question", "name": "Quelles sont les complications du TEV ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'embolie pulmonaire, l'insuffisance veineuse et le syndrome post-thrombotique." } }, { "@type": "Question", "name": "L'embolie pulmonaire est-elle grave ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'embolie pulmonaire peut être mortelle et nécessite une attention médicale immédiate." } }, { "@type": "Question", "name": "Qu'est-ce que le syndrome post-thrombotique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "C'est une complication chronique du TEV, entraînant douleur et gonflement persistants." } }, { "@type": "Question", "name": "Le TEV peut-il entraîner des problèmes cardiaques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une embolie pulmonaire peut provoquer des problèmes cardiaques en surchargeant le cœur." } }, { "@type": "Question", "name": "Comment gérer les complications du TEV ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut un suivi médical régulier et des traitements adaptés aux complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du TEV ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'immobilisation, l'obésité, les antécédents familiaux et certaines maladies." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de TEV ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de TEV augmente avec l'âge, surtout après 60 ans." } }, { "@type": "Question", "name": "Les femmes enceintes sont-elles à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la grossesse augmente le risque de TEV en raison des changements hormonaux et de la circulation." } }, { "@type": "Question", "name": "Les antécédents de TEV augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents de TEV augmente significativement le risque de récidive." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de formation de caillots sanguins." } } ] } ] }

Sources (7990 au total)

Predictive Value of Jugulo-omohyoid Lymph Nodes in Lateral Lymph Node Metastasis of Papillary Thyroid Cancer.

Jugulo-omohyoid lymph nodes (JOHLN) metastasis has proven to be associated with lateral lymph node metastasis (LLNM). This study aimed to reveal the clinical features and evaluate the predictive value... A total of 550 patients pathologically diagnosed with PTC between October 2015 and January 2020, all of whom underwent thyroidectomy and lateral lymph node dissection, were included in this study.... Thyroiditis, tumor location, tumor size, extra-thyroidal extension, extra-nodal extension, central lymph node metastasis (CLNM), and LLMM were associated with JOHLN. Male, upper lobe tumor, multifocal... JOLHN metastasis could be a clinically sensitive predictor of further LLM. A high-performance nomogram was established, which can provide an individual risk assessment of LNM and guide treatment decis...

Radiation, Lymph Node Dissection, or Both: Management of Lymph Node Micrometastases from Merkel Cell Carcinoma.

Regional lymph node micrometastases from Merkel cell carcinoma (MCC) can be treated with completion lymph node dissection (CLND) and/or radiation therapy (RT). It is unclear how these options compare ... This retrospective cohort study used data from years 2012-2019 of the National Cancer Database. Patients with MCC and clinically negative, but pathologically positive, lymph node metastases who receiv... A total of 962 patients were included [median (interquartile range) age, 74 (67-80) years, 662 (68.8%) male patients, 926 (96.3%) white patients]. The majority (63%, n = 606) had a CLND only, while 18... The usage of RT for nodal micrometastasis in MCC is increasing as compared with CLND. This strategy appears to be safe, with no significant difference in survival outcomes....

Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasized low rectal cancer.

Rectal or anal canal adenocarcinoma with inguinal lymph node metastasis (ILNM) is rare and is associated with poor prognostic outcomes. This study aimed to elucidate the clinical significance of neoad... This study enrolled 15 consecutive patients who underwent neoadjuvant therapy and curative resection for rectal or anal canal adenocarcinoma with clinically suspected ILNM between 2005 and 2019 at a s... Out of the15 patients, 11 were treated with neoadjuvant chemoradiation, three with chemotherapy, and one with chemoradiation followed by chemotherapy. Fluorodeoxyglucose (FDG)-positron emission tomogr... In patients with rectal or anal canal adenocarcinoma associated with clinical ILNM, radical resection with neoadjuvant therapy provides a good long-term survival....

Robotic versus laparoscopic total mesorectal excision with lateral lymph node dissection for advanced rectal cancer: A systematic review and meta-analysis.

Lateral pelvic node dissection (LPND) poses significant technical challenges. Despite the advent of robotic surgery, determining the optimal minimally invasive approach remains a topic of debate. This... This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) 2020 and AMSTAR 2 (Assessing the Methodological Quality of Systematic Revie... Six eligible studies involving 652 patients (316 and 336 in the R-LPND and L-LPND groups, respectively) were retrieved. The robotic approach demonstrated favourable outcomes compared with the laparosc... In summary, the robotic approach is a safe and feasible alternative for Total Mesorectal Excision (TME) with LPND in advanced rectal cancer. Notably, it is associated with lower morbidity, particularl...

Inguinal Lymph-Node Ratio (LNR) as a predictor of Pelvic Lymph-Node Metastasis in squamous cell carcinoma of penis.

To determine the predictors of pelvic lymph-node metastasis in cases of squamous cell carcinoma (SCC) of penis.... Data was retrospectively collected from 267 cases of SCC penis that presented at our institute between 2009 and 2019. Univariate and multivariate logistic regression models were used to identify indep... Pelvic Lymph-Node Metastasis (PLNM) was pathologically detected in 56 groins (29.2%). A cut-off of 0.25 was calculated for LNR based on ROC. LNR >0.25 (p = 0.003), ENE (p = 0.037), and LVI (p = 0.043)... LNR >0.25, LVI and, ENE are independent predictors of PLNM. The discriminative ability of LNR was better than PLN. PLND could be avoided if no risk factors are present....

Factors Associated With Lymph Node Yield and Effects of Lymph Node Density on Survival of Patients With Pulmonary Sarcomatoid Carcinoma.

The objective of this study was to identify factors associated with lymph node yield (LNY) during surgeries for pulmonary sarcomatoid carcinoma (PSC) and to determine effects of lymph node density (LN... The SEER Research Plus database was searched for data on patients with PSC from 1988 to 2018. Poisson regression was used of all patients with PSC to identify relevant factors associated with LNY. Uni... There were 545 eligible patients in the study sample, 175 of which were LN-positive. These patients had significantly lower 5-year OS than those with no positive LNs ( P <0.001). Poisson regression an... Patients with PSC with high LND experienced worse outcomes than those with low LND. Further risk stratification of patients with PSC may help to improve survival benefits based on prognostic indicator...

Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma.

The aim of this study is to assess the impact of lymph node ratio (LNR) and number of positive lymph nodes (NPLN) on mortality and recurrence rates in patients with laryngeal squamous cell carcinoma.... We conducted a retrospective multicenter international study involving 24 Otorhinolaryngology-Head and Neck Surgery divisions. Disease-specific survival (DSS) and disease-free survival (DFS) were eval... 2507 patients met the inclusion criteria. DSS and DFS were significantly different in the groups of patients stratified according to LNR and NPLN. The 5-year DSS and DFS based on LNR and NPLN demonstr... Our data demonstrate the potential prognostic value of NPLN and LNR in laryngeal squamous cell carcinoma....

Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved.

The metastatic lymph node (LN) ratio (LNR) has shown to be an important prognostic factor in various gastrointestinal malignancies. Nevertheless, the prognostic significance of LNR in gallbladder carc... From January 2007 to January 2018, 144 advanced GBC patients (T2-4 stages) who underwent curative surgery with at least 6 LNs retrieved were enrolled. Receiver operating characteristic (ROC) curve was... The optimal cut-off point for LNR was 0.28 according to the ROC curve. LNR>0.28 was associated with higher rate of D2 LN dissection (P=0.004) and higher tumor stages (P<0.001). Extent of liver resecti... LNR is correlated to advanced GBC prognosis and is a potential prognostic factor for advanced GBC with at least 6 LNs retrieved....

RATIO OF METASTATIC LYMPH NODES VS. RESECTED LYMPH NODES (N-RATIO) HAS PROGNOSTIC IMPLICATIONS IN GASTRIC CANCER.

Lymph node status is vital for gastric cancer (GC) prognosis, but the conventional pN stage may be limited by variations in lymphadenectomy and stage migration. The N-Ratio, which assesses the ratio o... To assess N-Ratios prognostic value in GC, particularly in patients with <25 resected lymph nodes.... Patients who underwent gastrectomy with curative intent for GC were retrospectively evaluated. The N-Ratio categories were determined using the ROC curve method, and the area under the curve (AUC) was... A total of 561 GC patients were included in the study, 57% had pN+ status, and 17.5% had <25 resected lymph nodes. N-Ratio, with a mean of 0.12, predicted survival with 74% accuracy (AUC=0.74; 95%CI 0... N-Ratio influenced survival in GC patients, especially in advanced lymph node disease (N-Ratio 3). Considering that N-Ratio does not impact pN0 cases, individualized prognosis assessment is essential ...